Table 2.
Organ system/therapeutic category/drug(s) | Pre-intervention N=200 n (%) |
Intervention N=200 n (%) |
p-value* |
---|---|---|---|
First-generation antihistamines | 32 (16.0) | 9 (4.5) | <0.001 |
Insulin, sliding scale | 37 (18.5) | 13 (6.5) | <0.001 |
Antispasmodics | 18 (9.0) | 7 (3.5) | 0.023 |
Alpha1 blockers | 14 (7.0) | 4 (2.0) | 0.016 |
Alpha agonists | 11 (5.5) | 5 (2.05) | 0.201 |
Antiarrhythmic drugs (class Ia, Ic, III) | 30 (15.0) | 12 (6.0) | 0.003 |
Digoxin | 11 (5.5) | 9 (4.5) | 0.646 |
Tertiary TCAs | 13 (6.5) | 4 (2.0) | 0.026 |
Antipsychotics | 13 (6.5) | 7 (3.5) | 0.169 |
Barbiturates | 13 (6.5) | 4 (2.0) | 0.044 |
Benzodiazepines | 19 (9.5) | 6 (3.0) | 0.007 |
Antiparkinson agents | 7 (3.5) | 3 (1.5) | 0.338 |
Sulfonylureas, long-duration | 31 (15.5) | 14 (7.0) | 0.007 |
Metoclopramide | 29 (14.5) | 11 (5.5) | 0.003 |
Meperidine | 11 (5.5) | 8 (4.0) | 0.638 |
Note:
Chi-square test.
Abbreviation: TCAs, tricyclic antidepressants.